id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-324265-j3v3i8vm	Marietta, Marco	COVID-19, coagulopathy and venous thromboembolism: more questions than answers	2020-07-11		.txt	text/plain	5031	242	37	The severity of the derangement of coagulation parameters in COVID-19 patients has been associated with a poor prognosis, and the use of low molecular weight heparin (LMWH) at doses registered for prevention of venous thromboembolism (VTE) has been endorsed by the World Health Organization and by Several Scientific societies. In these patients, low molecular weight heparin (LMWH) or unfractionated heparin (UFH) at doses registered for prevention of venous thromboembolism (VTE) seemed to be associated with a lower risk of death [10] and is currently recommended by the World Health Organization [11] and by several scientific societies [12] [13] [14] [15] [16] [17] [18] (Table 1) .	./cache/cord-324265-j3v3i8vm.txt	./txt/cord-324265-j3v3i8vm.txt